Related MeSH Hierarchy (6)
Diseases [C] » Infections [C01] » Communicable Diseases » Blood-Borne Infections » Hepatitis B » Hepatitis B, Chronic
Diseases [C] » Infections [C01] » Virus Diseases » Hepatitis, Viral, Human » Hepatitis B » Hepatitis B, Chronic
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Disease Attributes » Chronic Disease » Hepatitis, Chronic » Hepatitis B, Chronic
Diseases [C] » Digestive System Diseases [C06] » Liver Diseases » Hepatitis » Hepatitis, Chronic » Hepatitis B, Chronic
Diseases [C] » Digestive System Diseases [C06] » Liver Diseases » Hepatitis » Hepatitis, Viral, Human » Hepatitis B » Hepatitis B, Chronic
Diseases [C] » Infections [C01] » Virus Diseases » DNA Virus Infections » Hepadnaviridae Infections » Hepatitis B » Hepatitis B, Chronic
Description
INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. MeSH
Hierarchy View
Approved Indicated Drugs (5)
Phase 4 Indicated Drugs (35)
Phase 3 Indicated Drugs (5)
Phase 2 Indicated Drugs (55)
Phase 1 Indicated Drugs (56)
Other Experimental Indicated Drugs (30)
Organization Involved with Phase 4 Indications (135)
Asian-Pacific Alliance of Liver Disease, Beijing
Beijing Kawin Technology Share-Holding Co., Ltd.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Chinese University of Hong Kong
Daewoong Pharmaceutical Co. LTD.
Dalin Tzu Chi General Hospital
French National Agency for Research on AIDS and Viral Hepatitis
Fujian Cosunter Pharmaceutical Co. Ltd
Gottfried Wilhelm Leibniz Universität Hannover
Hannover Clinical Trial Center GmbH
Huazhong University of Science and Technology
Huizhou People's Central Hospital
Humanity & Health Research Centre
Icahn School of Medicine at Mount Sinai
Major Science and Technology Special Project of China Twelfth-Five-Year Project
Nanyang Technological University
National Cheng Kung University
National Health and Family Planning Commission, P.R.China
National University of Singapore
People's Liberation Army of China
Shenzhen Third People's Hospital
Shineway Pharmaceutical Co.,Ltd
Singapore Clinical Research Institute
Taichung Veterans General Hospital
Taipei Veteran General hospital
The Fifth People's Hospital of Suzhou
The Third Hospital of Qinhuangdao City
The Third People's Hospital of Taiyuan
Tung's Taiching MetroHarbor Hospital
Organization Involved with Phase 3 Indications (32)
Bangabandhu Sheikh Mujib Medical University
Centers for Disease Control and Prevention (CDC)
Organization Involved with Phase 2 Indications (68)
A2 Healthcare Taiwan Corporation
Ascletis Pharmaceuticals Co., Ltd.
Australian Respiratory and Sleep Medicine Institute
CHA Vaccine Institute Co., Ltd.
Guangzhou Baidi Biotechnology Co., Ltd
Guangzhou Pharmaceucal Company Limited
Huntington Medical Research Institutes
National Institute of Mental Health (NIMH)
National Institute on Drug Abuse (NIDA)
Organization Involved with Phase 1 Indications (26)
Organization Involved with Other Experimental Indications (18)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.